In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
Webinar Series on ESC Guidelines
More info

2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD

ESC Clinical Practice Guidelines

Diabetes and the Heart
Chronic Nursing Care
Risk Factors and Prevention
Guidelines version available to download
Published in 2019
Reference Diabetes
Published in 2014
Reference Corrigendum Diabetes
Published in 2019
Reference 
Published in 2019
Reference DIABET
Published in 2019
Reference Will be available shortly
App
Published in 2019
Reference DIABET
Table of contents: Full Text (ESC Clinical Practice Guidelines)
  • Abbreviations and acronyms
  • Preamble                            
  • Introduction
  • What is new in the 2019 Guidelines?
  • Cardiovascular risk assessment in patients with diabetes and pre-diabetes
    • Diabetes, pre-diabetes, and cardiovascular risk   
    •  Stratification of cardiovascular risk in individuals with  diabetes
    •  Stratification of cardiovascular risk in individuals with pre-diabetes
    • Clinical assessment of cardiovascular damage

  • Prevention of cardiovascular disease in patients with diabetes and pre-diabetes
    • Lifestyle
      • Diet
      • Physical Activity
      • Smoking
    • Glucose
    • Blood pressure
      • Treatment targets
      • Management of blood pressure lowering
    • Lipids
      • Lipid-lowering agents
    • Platelets
      • Aspirin
    • Multifactorial approaches
      • Principles pf multifactorial management
  •  Management of coronary artery disease
    • Medical treatment
      • Effect of intensified glucose control
      • Glucose lowering agents: new evidence from cardiovascular outcome trials
      • Specific macrovascular therapies
    • Revascularization
      • PCI vs CABG surgery
      • Adjunctive pharmacotherapy
  • Heart Failure and diabetes
    • Prognosis implications of diabetes Mellitus in heart failure
    • Mechanisms of left ventricular dysfunction in diabetes mellitus
    • Phenotypes of left ventricular dysfunction in diabetes mellitus
    • Effect of oral diabetes drugs on Heart failure
  •   Arrhythmias: atrial fibrillation, ventricular arrhythmias, and sudden cardiac death
    • Atrial fibrillation
    • Ventricular arrhythmias and sudden cardiac death
  • Aortic and peripheral arterial diseases
    • Aortic disease
    • Lower extremity arterial disease
    • Carotid artery disease
  • Chronic kidney disease in diabetes
    • Management
  • Patient-centred care
    • General aspects
  • What "to do" and what "not to do", messages from the Guidelines
  • Appendix
  • References
Previous version available to download
Published in 2013
Reference Eur Heart J 2013;34:3035-3087
Published in 2013
Reference DIABET
Published in 2013
Reference Slide-set on Diabetes
Published in 2007
Reference European Heart Journal Supplements (2007) 9 (Supplement C), C3–C74; doi:10.1093/eurheartj/ehl261
Published in 2007
Reference EHJ 2007;28:88-136
Published in 
Reference